Search Results for: clinicaltrials.gov

Call to patients: let’s advocate together for stem cell clinic publishing

/ / 21 Comments

In this post I propose that researchers and patients advocate together to pressure the stem cell clinic industry to collect and publish such data. Why do I make such a proposal? Many thousands of patients have bought stem cell interventions from non-compliant stem cell clinics. Thousands of others are considering doing so. You can see […]

Call to patients: let’s advocate together for stem cell clinic publishing Read More »

Kathy Ireland Stemáge Stem Cell Product: Part 1, is it a drug?

/ / 7 Comments
Kathy-Ireland-300x2191

I was alerted by a friend to the fact that there are now YouTube ads for stem cell products popping up, and one such ad features supermodel Kathy Ireland pitching for something called Stemáge Skin Care. Updated (May 23): note that preliminary word from Sanford-Burnham is that they are not collaborating on Stemáge. Today’s post is

Kathy Ireland Stemáge Stem Cell Product: Part 1, is it a drug? Read More »

SVF & CAL are two fat stem cell acronyms generating a lot of buzz

/ / 9 Comments

Two emerging acronyms in the for-profit stem cell world that remain unknown to most academic stem cell scientists, but that are generating the most buzz are: SVF and CAL. These are two fat acronyms. What? These acronyms relate to adipose (fat) stem cell-based procedures. SVF stands for “stromal vascular fraction”. SVF is, for lack of

SVF & CAL are two fat stem cell acronyms generating a lot of buzz Read More »

RNL Bio files IND with Korean FDA to transplant adult stem cells to treat cerebral palsy: what’s the scoop?

/ / 6 Comments

The Korean-based stem cell biotech, RNL Bio, which also does business in the U.S. as RNL Bio and Human Biostar Inc, reportedly (seems to be a press release, PR) has filed an investigational new drug (IND) application with the Korean FDA (KFDA). The purpose of the application is to test the efficacy of autologous adult stem cells

RNL Bio files IND with Korean FDA to transplant adult stem cells to treat cerebral palsy: what’s the scoop? Read More »

Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC)

/ / 4 Comments

For the second year in a row (see awards 2011), Advanced Cell Technology (ACT; stock symbol ACTC) is my stem cell biotech of the year. Their trials for different forms of macular degeneration (here and here and here) are progressing well and as a stem cell scientist I really appreciate the fact they are publishing their

Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC) Read More »

Mapping global trends in MSC & stem cell clinical trials: unexpected findings

/ / 2 Comments

One of the most exciting types of stem cells are mesenchymal stem cells or MSCs. Although there is some debate about these cells (e.g. I once heard Irv Weissman say at a meeting he wasn’t sure they really existed as such), a consensus would seem to be that they have great potential medical potential. Perhaps

Mapping global trends in MSC & stem cell clinical trials: unexpected findings Read More »

Stem cells for COPD including emphysema: are we there yet?

/ / 3 Comments

Chronic obstructive pulmonary disease (COPD) is a relatively common, often debilitating illness, which has a major impact on the people of the world. In the U.S. alone, COPD costs the country almost $50 billion a year not to  mention untold suffering. Most of us know someone who has COPD. COPD is an umbrella term that

Stem cells for COPD including emphysema: are we there yet? Read More »